Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00184015
Status:
UNKNOWN
Last Update Posted:
2017-04-11
First Post:
2005-09-12
Brief Title:
Bortezomib and Bevacizumab BB-mib-mab in Patients With Advanced or Recurrent Renal Cell Cancer RCC
Sponsor:
University of Southern California
Organization:
University of Southern California
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-08-18
Start Date Type:
ACTUAL
Primary Completion Date:
2016-08-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08-21
Completion Date Type:
ESTIMATED
First Submit Date:
2005-09-12
First Submit QC Date:
September 12 2005
Study First Post Date:
2005-09-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-08
Last Update Post Date:
2017-04-11
Last Update Post Date Type:
ACTUAL